Skip to main content

Disturbed Regulation of Aldosterone and Sodium Excretion in a Subgroup of Essential Hypertensives

  • Conference paper
Hypertension: Mechanisms and Management

Part of the book series: International Boehringer Mannheim Symposia ((BOEHRINGER))

  • 27 Accesses

Abstract

The phenomenon of low plasma renin activity in approximately 25% of essential hypertensives has initiated a great deal of interest into investigating signs of mineralocorticoid excesss in these patients. The results obtained were highly controversial. However, several abnormalities in mineralocorticoid production in patients with essential hypertension have been reported by the groups of Melby [12] and Genest [5, 6] and Luetscher [2, 4] demonstrating an inappropriate suppression of aldosterone secretion in essential hypertensives by sodium loading.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benraad H, Drayer J, Hoefnagels W, Kloppenburg P, Benraad T (1978) Role of aldosterone in antihypertensive effect of spironolactone in essential hypertension. Clin Pharmacol Ther 24: 638

    PubMed  CAS  Google Scholar 

  2. Collins RD, Weinberger MH, Dowdy AJ, Nokes GW, Gonzales CM, Luetscher JA (1970) Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension, relation to plasma renin activity. J Clin Invest 49: 1415

    Article  PubMed  CAS  Google Scholar 

  3. Ferriss JB, Beevers DG, Brown JJ, Davies DL, Fraser R, Lever AF, Mason P, Neville AM, Robertson JIS (1978) Clinical, biochemical and pathological features of low-renin (“primary”) hyperaldosteronism (Review). A Heart J 95: 375

    Article  CAS  Google Scholar 

  4. Ferriss JB, Beevers DG, Brown JJ, Fraser R, Lever AF, Padfield PL, Robertson JIS (1978) Low-renin (“primary”) hyperaldosteronism. Differential diagnosis and distinction of subgroups within the syndrome (Review). Am Heart J 95: 641

    Article  PubMed  CAS  Google Scholar 

  5. Genest J, Nowaczynski W, Kuchel O, Sasaki C (1972) Plasma progesterone levels and 18-Hydroxy-deoxycorticosterone secretion rate in benign essential hypertension in humans. In: Genest J, Koiw (eds) Hypertension 72. Springer, Berlin Heidelberg New York, p 293

    Google Scholar 

  6. Genest J, Nowaczynski W, Kuchel O, Sasaki C, Boucher R, Rojo-Ortega JM, Constantinopoulos G, Ganten D, Messerli F (1976) The adrenal cortex and essential hypertension. Recent Prog Horm Res 32: 377

    PubMed  CAS  Google Scholar 

  7. Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrin 29: 1349

    Article  CAS  Google Scholar 

  8. Helber A, Kaufmann W (1973) Radioimmunologische Methode zur Aldosteronbestimmung im Urin. Klin Wochenschr 51: 1164

    Article  PubMed  CAS  Google Scholar 

  9. Helber A, Meurer KA, Rosskamp E, Wambach G, Dickmans HA, Kaufmann W (1974) Aldosteronexkretion und Plasmareninaktivität von Patienten mit essentieller Hypertonie und mit reninsupprimiertem Hyperaldosteronismus. Klin Wochenschr 52: 966

    Article  PubMed  CAS  Google Scholar 

  10. Kloppenburg PWC, Drayer JIM, Benraad HB, Benraad TJ (1974) Normal aldosterone versus supranormal aldosterone hypertension: An alternative to normal renin versus low renin hypertension. In: Distler A, Wolff HP, (eds) Current problems in hypertension. Thieme, Stuttgart, p 143

    Google Scholar 

  11. Luetscher JA, Beckerhoff R, Dowdy AJ, Wilkinson R (1972) Incomplete suppression of aldosterone secretion and plasma concentration in hypertensive patients on high sodium intake. In: Genest J, Koiw (eds) Hypertension 72. Springer, Berlin Heidelberg New York, p 286

    Google Scholar 

  12. Melby JC, Dale SL, Wilson TE (1971) 18-Hydroxy-DOC in human hypertension. Circ Res Suppl II 28: 143

    PubMed  Google Scholar 

  13. Spark RF, Melby JC (1968) Aldosteronism in hypertension. Ann Intern Med 69. 685

    PubMed  CAS  Google Scholar 

  14. Spark RF, Melby JC (1971) Hypertension and low plasma renin activity: Presumptive evidence for mineralocorticoid excess. Ann Int Med 75: 831

    PubMed  CAS  Google Scholar 

  15. Yeoman GD, Dustan HP, Tarazi RC, Bravo EL (1976) Hypertension, obesity and blood volume. Abstract, Kidney 110: 538

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Helber, A., Wambach, G., Hummerich, W., Bönner, G., Meurer, K.A., Kaufmann, W. (1980). Disturbed Regulation of Aldosterone and Sodium Excretion in a Subgroup of Essential Hypertensives. In: Philipp, T., Distler, A. (eds) Hypertension: Mechanisms and Management. International Boehringer Mannheim Symposia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67712-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67712-0_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-10171-0

  • Online ISBN: 978-3-642-67712-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics